Academic History

Bradley McGregor, MD, is currently Director of Clinical Research for the Lank Center of Genitourinary Oncology at the Dana-Farber Cancer Institute, Boston, MA, and Assistant Professor of Medicine at Harvard Medical School, Boston, MA. Dr McGregor received his medical degree at Tufts University School of Medicine, Boston, MA, and joined the United States Air Force, where he competed his residency and fellowship at the San Antonio Uniformed Services Health Education Consortium, San Antonio, TX.

Speaking on genitourinary cancer clinical and translational research

Dr McGregor’s research focuses on advancing treatments for kidney, bladder, prostate, and other genitourinary cancers through clinical and translational research. He leads and contributes to early- and late-phase clinical trials evaluating novel targeted therapies, immunotherapies, and combination treatment strategies. His work is particularly centered on improving outcomes in renal cell carcinoma and urothelial carcinoma, investigating mechanisms of treatment response and resistance, and developing precision medicine approaches to optimize patient care.